Editorial Partner Network
An editorial partner network for women's health.
Built with writers, clinicians, and creators who share our standards — research-grounded, vendor-neutral, citation-first. Editorial access and attribution now; paid affiliate access when Anthivera+ launches in 2026.
Why a network, not an affiliate program
Editorial currency first. Commerce later.
We're building the network we already cite
Anthivera's reviews lean on the work of women's-health writers, clinicians, and researchers. The partner network formalizes that — the people whose work we trust become the people we share early access with.
Editorial currency, not commission
Partners get early access to research reviews and provider scorecards before public release, attribution where their expertise applies, and a direct line to our editors. No promotion targets. No required posting.
When commerce launches, you're first
Anthivera+ Premium opens in 2026. Editorial partners are invited to the paid affiliate program the day it goes live — terms shared with the network ahead of public announcement.
The fit
For women whose work is already in this space.
We're looking at audience fit and editorial alignment — not follower counts. Application reviewed by hand within two weeks.
- Women's-health writers, journalists, and newsletter editors
- Perimenopause, fertility, and menopause coaches
- Functional medicine and integrative practitioners with a women-focused practice
- Women's wellness creators on Substack, Instagram, YouTube, and Podcasts
- OB/GYNs, nurse practitioners, and PAs serving women's health
What partners get
Access, attribution, a real editorial line.
EARLY ACCESS
Research reviews + provider scorecards before public release
See our drafts before they go live. Quarterly provider rescoring, peptide entries, and long-form pieces — sent to the network first, with a quiet review window.
ATTRIBUTION
Cited in our published work
Where your published work, clinical practice, or audience research informs ours, we cite you by name. Editorial credit, mutual respect — the citation chain works both ways.
PARTNER KIT
On-brand assets to share — when it fits
Banners, social tiles, copy variants, and pre-written intro paragraphs. Use them when a piece fits your audience. No promotion targets, no required posting.
DIRECT LINE
A real editorial contact
Your partner contact reads every message. Audience fit questions, fact-checks, source recommendations, draft feedback — handled in the same week, by a person who knows the work.
CONTRIBUTE
Publish original work on Anthivera
Pitch a piece — research synthesis, clinical perspective, evidence review — for publication on Anthivera. Light editing, generous citation, permanent byline. Submission details on /contribute.
What we ask
Editorial alignment — that's it.
No promotion targets, no required posting, no scoring of participation. A network is reciprocal, but the reciprocity is editorial, not transactional.
- Editorial alignment with our standards: cited, vendor-neutral, research-grounded.
- Honest feedback on drafts where your expertise applies.
- Disclosure of any commercial relationships that could shape your input.
- When you do share Anthivera with your audience, it follows the disclosure language in our affiliate disclosure.
How it works
Apply, reviewed, joined.
- 01
Apply
Tell us about your audience, your work, and where you'd promote — when it fits. We read every application by hand.
- 02
Review
We confirm audience fit and editorial alignment. Slow and careful, the same way we review providers. Reply within two weeks.
- 03
Join
Approved partners receive their first invitation — usually an early draft of a peptide entry or a provider scorecard refresh — within their first month. Anthivera+ affiliate program invitation follows when the program opens.
Request to join
Leave your email.
We'll reply with the full application — your audience, your work, and how you talk about women's health — and add you to the priority list for the Anthivera+ affiliate program when it opens.
Or email hello@anthivera.com directly with “Editorial Partner Network” in the subject. See our affiliate disclosure for the full disclosure language we use on-site.
FAQ
Common questions.
- Is this an affiliate program?
- Not yet. The Editorial Partner Network is Phase 1 — editorial access and attribution, no money exchanged. When Anthivera+ Premium launches in 2026, the paid affiliate program opens, and approved partners are invited first.
- Who qualifies?
- Women's-health writers, clinicians, coaches, and creators whose audience and editorial standards fit. We're not gating on follower counts — we're looking at the work itself.
- Do I have to promote anything?
- No. The network has no promotion targets, no required posts, no minimum activity. If you share Anthivera when something genuinely fits your audience, great. If you never share publicly, that's also fine — your value to the network is editorial alignment, not amplification.
- Can I pitch a piece to publish on Anthivera?
- Yes. Pitches are open to any qualified writer — accepted contributors automatically join the network. See /contribute for the formats we publish, editorial standards, and exactly what to include in your pitch.
- What happens when Anthivera+ launches?
- Approved partners hear the launch date, pricing, and exact commission terms before public announcement. You can opt into the paid affiliate program then — or stay editorial-only. Both paths stay open.
- What about the editorial firewall?
- Provider reviews and ratings are independent of any commercial relationship. Partners promote Anthivera as a publication — not specific providers, peptides, or medical advice. See our affiliate disclosure for the full on-site language.